FDA approves new tracheal intubation drug

Jun 10, 2020 - 02:44 PM
FDA product update

The Food and Drug Administration Monday approved a new injection to assist in tracheal intubation and provide muscle relaxation during surgeries or mechanical ventilation. FDA said side effects include anaphylaxis, hyperkalemia and malignant hyperthermia.

Related News Articles

Headline
NIH, FDA act to increase access to over-the-counter COVID-19 tests
The National Institutes of Health will use $70 million from the American Rescue Plan Act for a program to speed development of accurate and reliable over-the-…
Headline
FDA greenlights injection to aid tracheal intubation
The Food and Drug Administration last week approved a new drug for facilitating tracheal intubation and to provide skeletal muscle relaxation during surgery or…